Ozempic

Spotlight

EU approves Regeneron’s bispecific antibody following US rejection FDA approval of Regeneron’s myeloma drug delayed due to manufacturing issues Breaking News: Lecanemab approved in UK but unavailable on NHS First bispecific CAR-T therapy for MS receives green light from FDA to start phase 1 Adcendo and Multitude target cancer resistance to ADCs in $1BN deal

Follow us

Most popular News

• 1 Adcendo and Multitude target cancer resistance to ADCs in $1BN deal
• 2 ArsenalBio bags $325 million to develop CRISPR-engineered cell therapies
• 3 EU and UK approve Microbiome Medicines for advanced melanoma and ulcerative colitis
• 4 New oral cholera vaccine brings hope for global public health
• 5 Orgenesis touts early clinical promise of CAR-T therapy with decentralized production in mind

Webinars

Upcoming supplier webinars

• 17 Sep 2024 Tue Manufacturing Friendly Aggregate Clearance in Downstream Processing of Bispecific and Traditional Antibodies Using a Novel POROS Mixed-Mode Chromatography Media Thermo Fisher Scientific - Biosciences

Featured Suppliers

All

• Nicoya Lifesciences
• Thermo Fisher Scientific Gibco Culture for Bioprocessing
• WuXi AppTec